
Matthew T. Harting, MD, MS, FACS
- Associate Professor
- Medical Director, Pediatric ECMO Program
- Medical Director, Pediatric Surgery Telemedicine Program
- Co-Director, High-risk, Multi-Disciplinary Clinic for CDH
Contact
Matthew T. Harting, MD, MS, FACS713.500.7300
713.500.7296 fax
Jacqueline Franco
713.500.5168
Biography
Dr. Matthew Harting is an Associate Professor at McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) in the Department of Pediatric Surgery. He is certified by the American Board of Surgery in general surgery, pediatric surgery and surgical critical care. A Texas native, Dr. Harting grew up in the Austin area and received his undergraduate degree from the University of Texas at Austin in the Dean’s Scholars Honors program in the College of Natural Sciences. He received his medical degree, as well as a master of science in clinical research, from the University of Texas Medical School at Houston, and completed his surgical residency at the University of Michigan. During his surgical training, he completed an NIH T32 and T15 sponsored clinical, translational, and basic science research fellowship in adult stem cell therapies and trauma. An additional post-graduate fellowship was completed in Pediatric Surgery at the University of Washington Seattle Children’s Hospital and he completed a Surgical Critical Care fellowship at the University of Texas Medical School at Houston. Dr. Harting is board certified in Surgery and Pediatric Surgery.
Dr. Harting’s clinical interests include congenital and acquired thoracic disease, including pulmonary, diaphragmatic, and esophageal disease. He has particular interest in patients with congenital diaphragmatic hernias. He also has interest in minimally invasive surgery and extracorporeal life support (ELS or ECMO). Dr. Harting is the director of the pediatric ECMO program.
Dr. Harting is a clinical and basic-translational scientist with interests in pulmonary disease and stem cell biology. His primary research is focused on congenital diaphragmatic hernia and the concomitant pulmonary pathophysiology. He is investigating novel, cell-based therapies as treatment strategies for congenital pulmonary disease. Additionally, he is involved in the Center for Surgical Trials and Evidence Based Practice.
Education
- BA
- Microbiology - University of Texas at Austin, Austin, TX, 1999
- MD
- Doctor of Medicine - University of Texas Medical School at Houston, Houston, TX, 2003
- MS
- Clinical Research - University of Texas, Schools of Medicine and Public Health, Houston, TX, 2004
- Residency
- General Surgery - University of Michigan, Ann Arbor, MI, 2011
- Fellowship
- Pediatric Surgery - University of Washington, Seattle Children's Hospital, Seattle, WA, 2013
- Fellowship
- Surgical Critical Care - University of Texas Medical School at Houston, Houston, TX, 2014
Areas of Interest
Clinical Interests
- Congenital and acquired thoracic disease (pulmonary, diaphragmatic, & esophageal)
- Congenital diaphragmatic hernia
- Minimally invasive surgery (laparoscopy & thoracoscopy)
- Extracorporeal life support (ELS or ECMO)
Research Interests
Matthew T. Harting, MD, MS, Congenital Diaphragmatic Hernia
Matthew T. Harting, MD, MS, Assistant Professor in the Department of Pediatric Surgery at McGovern Medical School, focuses on pulmonary disease and stem cell biology in children. His research focuses on congenital diaphragmatic hernia, a birth defect that creates a hole in the diaphragm in one out of 2,500 children and leads to abnormal blood vessels in the lungs. To learn how you can make a difference, please call (713) 500-3200 or visit www.uth.edu/giving.
- Pulmonary disease
- Congenital diaphragmatic hernia
- Stem cell biology